Kalaris Therapeutics Inc (KLRS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022
    Period Ending Dec 31, 2023 Dec 31, 2022
    Cash & Equivalents
    		 3.17M 3.06M
    Short-Term Investments
    		 n/a n/a
    Long-Term Investments
    		 n/a n/a
    Other Long-Term Assets
    		 n/a n/a
    Receivables
    		 n/a n/a
    Inventory
    		 n/a n/a
    Other Current Assets
    		 n/a n/a
    Total Current Assets
    		 3.33M 3.9M
    Property-Plant & Equipment
    		 n/a n/a
    Goodwill & Intangibles
    		 n/a n/a
    Total Long-Term Assets
    		 n/a n/a
    Total Assets
    		 3.33M 3.9M
    Account Payables
    		 2.36M 2.76M
    Deferred Revenue
    		 n/a n/a
    Short-Term Debt
    		 n/a n/a
    Other Current Liabilities
    		 540K 296K
    Total Current Liabilities
    		 3.94M 5.69M
    Long-Term Debt
    		 n/a 3.25M
    Other Long-Term Liabilities
    		 44.41M 25.23M
    Total Long-Term Liabilities
    		 44.41M 28.48M
    Total Liabilities
    		 48.35M 34.17M
    Total Debt
    		 n/a 3.25M
    Book Value
    		 -45.02M -30.27M
    Book Value Per Share
    		 n/a n/a
    Common Stock
    		 n/a n/a
    Retained Earnings
    		 -47.39M -32.7M
    Comprehensive Income
    		 n/a n/a
    Shareholders Equity
    		 -45.02M -30.27M
    Total Investments
    		 n/a n/a

    Add to Watchlist